IBRX ImmunityBio
- 6.100
- +0.010+0.16%
- 6.160
- +0.060+0.98%
ImmunityBio News
Express News | Immunitybio Announces 2024 Annual Meeting of Stockholders With Company Update
ImmunityBio, LadRx End Licensing Deal for Cancer Drug
Daily options tracking | Gamestop surged 21% overnight, one call option yielded a profit of 9 times; Nvidia call options ratio increased to 60%, multiple call options were traded vigorously.
Dell fell more than 5% overnight, with options volume of 250,000 contracts, nearly doubled from the daily average volume. The call/put ratio rose to 65%, causing volatile sentiment in the options chain. Active transactions include the call with a strike price of $140 and the put with a strike price of $1,300, both expiring this Friday, with trading volumes of 13,000 contracts and 11,000 contracts respectively, both with open interest of nearly 3,000 contracts. In addition, the premium for multiple puts expiring on the same day doubled.
Express News | Ladrx and Immunitybio mutually agree to terminate the Aldoxorubicin license.
Express News | Ladrx and Immunitybio Mutually Agree to Terminate Aldoxorubicin License
Viking, CRISPR, Intellia Among Potential M&A Targets: Wells Fargo
How Is The Market Feeling About ImmunityBio?
ImmunityBio's (NYSE:IBRX) short percent of float has fallen 8.79% since its last report. The company recently reported that it has 55.14 million shares sold short, which is 35.26% of all regular share
ImmunityBio First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
ImmunityBio (IBRX.US): The 2024 Q1 financial report achieved revenue of 40,000 US dollars, the previous value was 360,000 US dollars, the expected value was 20,000 US dollars; earnings per share were -0.20 US dollars, the previous value was -0.27 dollars,
ImmunityBio (IBRX.US): The 2024 Q1 financial report achieved revenue of 40,000 US dollars, the previous value was 360,000 US dollars, the expected value was 20,000 US dollars; earnings per share were -0.20 US dollars, the previous value was -0.27 dollars, and the expected value was -0.16 US dollars.
ImmunityBio | 10-Q: Quarterly report
ImmunityBio Shares Rise After Completion of Drug Substance Manufacturing for Cancer Treatment
ImmunityBio (IBRX) shares rose almost 10% in recent trading after the company shared the completion and qualification Tuesday of the drug substance for filling vials and finishing packaging enough for
Tempur Sealy Posts Upbeat Earnings, Joins FibroGen, Coca-Cola Consolidated, Fabrinet And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were higher, with the Dow Jones gaining over 80 points on Tuesday.Shares of Tempur Sealy International, Inc. (NYSE:TPX) rose sharply during Tuesday's session following upbeat quarterly ear
ImmunityBio Completes GMP Drug Substance Manufacturing Sufficient For 170,000 Doses Of ANKTIVA
ANKTIVA Drug Substance completed and released with two-year storage stability data sufficient for 170,000 doses of ANKTIVA productImmunityBio's 400,000 square foot GMP fill-finish facility in Dunkirk,
Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (BMRN), Idexx Laboratories (IDXX) and ImmunityBio (IBRX)
Social Buzz: Wallstreetbets Stocks Mixed Pre-Bell Monday; Palantir to Advance, Trump Media & Technology Group to Decline
The most-talked-about stocks in the Reddit subforum Wallstreetbets were mixed hours before Monday's opening bell. Palantir (PLTR) rose by 3.5% hours before the opening bell, still up after a 3.5% incr
Serum Institute of India Inks Large-Scale Supply Deal For BCG Use In ImmunityBio's Bladder Cancer Combo Therapy
ImmunityBio Inc (NASDAQ:IBRX) shares are trading down after an early morning high on Friday after the company announced an exclusive global arrangement with the Serum Institute of India, the world's l
Amgen Posts Upbeat Results, Joins OneSpan, Paylocity Holding, MercadoLibre And Other Big Stocks Moving Higher On Friday
U.S. stocks were higher, with the Dow Jones index gaining over 400 points on Friday.Shares of Amgen Inc. (NASDAQ:AMGN) rose sharply during Friday's session after the company reported better-than-expec
S&P 500 Futures Up In Premarket Trading; Amgen, ImmunityBio Lead
This article was automatically generated by Barrons.com using technology from Automated Insights. With U.S. stock markets set to open in two hours, Amgen Inc. (AMGN) was up 13.6% in pre-market tradin
Social Buzz: Wallstreetbets Stocks Mixed Pre-Bell Friday; ImmunityBio to Advance, Boeing to Decline
The most-talked-about stocks in the Reddit subforum Wallstreetbets were mixed hours before Friday's opening bell. ImmunityBio (IBRX) advanced by 7.9% in premarket activity, adding to its 5% increase f
ImmunityBio Shares Are Trading Higher After the Company Announced It Signed an Exclusive Global Arrangement With the Serum Institute of India. The Company Will Be Supplied With Bacillus Calmette-Guerin.
ImmunityBio Shares Are Trading Higher After the Company Announced It Signed an Exclusive Global Arrangement With the Serum Institute of India. The Company Will Be Supplied With Bacillus Calmette-Gueri
Analysis
Price Target
No Data
